Skip to content
Disclosery

Data Collective IV GP, LLC

Follow

13F filer, CIK 1664974, PALO ALTO, CA

Data Collective IV GP, LLC reported $55,949,943 across 4 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-062465

Period
2026-03-31
Reported value
$55.9M
Holdings
4
Top 10 weight
100%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
HQnew+915,198$8.04M
DFTXnew+100,350$1.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MIND MEDICINE MINDMED INCexited-100,350-$1.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001104659-26-062465, largest first. % of portfolio is the value over $55,949,943, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EVLVEVOLV TECHNOLOGIES HLDNGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,681,281 shares; 2024Q4: 9,681,281 shares; 2025Q1: 9,681,281 shares; 2025Q2: 9,681,281 shares; 2025Q3: 5,000,000 shares; 2025Q4: 4,590,000 shares; 2026Q1: 4,590,000 shares 4,590,000$27.8M49.63%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,941,120 shares; 2024Q4: 5,941,120 shares; 2025Q1: 5,941,120 shares; 2025Q2: 5,941,120 shares; 2025Q3: 5,941,120 shares; 2025Q4: 5,941,120 shares; 2026Q1: 5,941,120 shares 5,941,120$18.2M32.6%0Timeline
HQHORIZON QUANTUM HOLDINGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 915,198 shares 915,198$8.04M14.38%newTimeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,350 shares 100,350$1.9M3.39%newTimeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INC100,350$1.34Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-062465 base2026-05-15acceptance time not in the bulk data set